Acad Emerg Med

1. KALTISO SO, Seitz RM, Zdradzinski MJ, Moran TP, et al
   The impact of racism on emergency health care workers.
   Acad Emerg Med. 2021 Aug 6. doi: 10.1111/acem.14347.
   

   >> Share

   
   

   
   AJR Am J Roentgenol

2. HAMMER MM
   Real-World Diagnostic Performance of RSNA Consensus Reporting Guidelines for Findings Related to COVID-19 on Chest CT.
   AJR Am J Roentgenol. 2021 Aug 4. doi: 10.2214/AJR.21.26560.
   

   >> Share

   
   

   
   Am J Obstet Gynecol

3. SUN H
   Adjustment is Required to Calculate the Risk of Early Pregnancy Loss with Covid-19 Infection or Vaccination.
   Am J Obstet Gynecol. 2021 Aug 3. pii: S0002-9378(21)00861.
   

   >> Share

   
   
4. SCHWARTZ A, Nir O, Toussia-Cohen S, Leibovich L, et al
   Presence of SARS-CoV-2 antibodies in lactating women and their infants following BNT162b2mRNA vaccine.
   Am J Obstet Gynecol. 2021 Aug 2. pii: S0002-9378(21)00831.
   

   >> Share

   
   
5. PACHECO LD, Berry M, Saad AF, Yates SG, et al
   Coagulation assessment with viscoelastic testing in asymptomatic post-partum patients with SARS-CoV-2 infection: a pilot study.
   Am J Obstet Gynecol. 2021 Jul 28. pii: S0002-9378(21)00826.
   

   >> Share

   
   

   
   Am J Respir Crit Care Med

6. CARLOS WG, Gross JE, Cruz CD, Jamil S, et al
   Monoclonal Antibodies: Medical Uses for the Prevention and Treatment of Disease.
   Am J Respir Crit Care Med. 2021;203:P26-P27.
   

   >> Share

   
   

   
   Ann Intern Med

7. AGARWAL A, Lang E
   In adults hospitalized with COVID-19, the 5-variable SOARS score predicted in-hospital mortality.
   Ann Intern Med. 2021 Aug 3. doi: 10.7326/ACPJ202108170.
   

   >> Share

   
   
8. CLIFT AK, Saatci D, Coupland CAC, Dambha-Miller H, et al
   Sickle Cell Disorders and Severe COVID-19 Outcomes: A Cohort Study.
   Ann Intern Med. 2021 Jul 20. doi: 10.7326/M21-1375.
   

   >> Share

   
   
9. CHAGLA Z
   In patients with COVID-19, viral shedding time is 17 d and varies in some subgroups.
   Ann Intern Med. 2021 Aug 3. doi: 10.7326/ACPJ202108170.
   

   >> Share

   
   

   
   BMJ

10. TAYLOR L
    Covid-19: WHO calls for booster shot ban until end of September.
    BMJ. 2021;374:n1962.
    

    >> Share

    
    
11. MAHASE E
    Covid-19: All 16 and 17 year olds in the UK to be offered first vaccine dose.
    BMJ. 2021;374:n1958.
    

    >> Share

    
    
12. MAHASE E
    Covid-19: CPAP reduces need for invasive mechanical ventilation in patients requiring oxygen, study finds.
    BMJ. 2021;374:n1950.
    

    >> Share

    
    
13. MAHASE E
    Covid-19: Pfizer vaccine's efficacy declined from 96% to 84% four months after second dose, company reports.
    BMJ. 2021;374:n1920.
    

    >> Share

    
    
14. DYER O
    Covid-19: Delta infections threaten herd immunity vaccine strategy.
    BMJ. 2021;374:n1933.
    

    >> Share

    
    
15. O'DOWD A
    Covid 19: Most patients in England received good or excellent care in hospital, finds analysis.
    BMJ. 2021;374:n1935.
    

    >> Share

    
    
16. BAMJI AN
    Infection with SARS-CoV-2 is not the same as covid-19.
    BMJ. 2021;374:n1896.
    

    >> Share

    
    
17. ERFANI P, Binagwaho A, Jalloh MJ, Yunus M, et al
    Intellectual property waiver for covid-19 vaccines will advance global health equity.
    BMJ. 2021;374:n1837.
    

    >> Share

    
    
18. MAHASE E
    Covid-19: Most symptomatic children recover within a week, study finds.
    BMJ. 2021;374:n1947.
    

    >> Share

    
    

    
    Clin Chem

19. CAO J, Liu X, Muthukumar A, Gagan J, et al
    Poor Humoral Response in Solid Organ Transplant Recipients following Complete mRNA SARS-CoV-2 Vaccination.
    Clin Chem. 2021 Aug 6. pii: 6343450. doi: 10.1093.
    

    >> Share

    
    
20. ZHANG Y, Ong CM, Yun C, Mo W, et al
    Diagnostic Value of Nucleocapsid Protein in Blood for SARS-CoV-2 Infection.
    Clin Chem. 2021 Aug 6. pii: 6343449. doi: 10.1093.
    

    >> Share

    
    

    
    Clin Infect Dis

21. LI P, Ikram A, Peppelenbosch MP, Ma Z, et al
    Systematically Mapping Clinical Features of Infections With Classical Endemic Human Coronaviruses.
    Clin Infect Dis. 2021;73:554-555.
    

    >> Share

    
    
22. CASADEVALL A, Joyner MJ, Pirofski LA
    Implications of Coronavirus Disease 2019 (COVID-19) Antibody Dynamics for Immunity and Convalescent Plasma Therapy.
    Clin Infect Dis. 2021;73:e540-e542.
    

    >> Share

    
    
23. BIGGERSTAFF M, Slayton RB, Johansson MA, Butler JC, et al
    Improving Pandemic Response: Employing Mathematical Modeling to Confront COVID-19.
    Clin Infect Dis. 2021 Aug 3. pii: 6338173. doi: 10.1093.
    

    >> Share

    
    
24. XIANG F, Sun J, Chen PH, Han P, et al
    Early Elevation of Fibrosis-4 Liver Fibrosis Score Is Associated With Adverse Outcomes Among Patients With Coronavirus Disease 2019.
    Clin Infect Dis. 2021;73:e594-e601.
    

    >> Share

    
    
25. FOURATI S, Bailly B, Le Bouter A, Guilpain L, et al
    Differential anti-S antibody titers in vaccinated residents during an outbreak of SARS-CoV-2 variant B.1.351 (beta) in an elderly nursing home.
    Clin Infect Dis. 2021 Aug 3. pii: 6338175. doi: 10.1093.
    

    >> Share

    
    
26. LAWANDI A, Warner S, Sun J, Demirkale CY, et al
    Suspected SARS-CoV-2 Reinfections: Incidence, Predictors, and Healthcare Use among Patients at 238 U.S. Healthcare Facilities, June 1, 2020- February 28, 2021.
    Clin Infect Dis. 2021 Aug 5. pii: 6342166. doi: 10.1093.
    

    >> Share

    
    
27. PADHI S, Pati A, Panda AK
    Effect of ivermectin in the treatment of COVID-19: A trial sequential analysis highlighted the requirement of additional randomized controlled trials.
    Clin Infect Dis. 2021 Aug 6. pii: 6343157. doi: 10.1093.
    

    >> Share

    
    
28. COLEMAN KK, Tay DJW, Sen Tan K, Ong SWX, et al
    Viral Load of SARS-CoV-2 in Respiratory Aerosols Emitted by COVID-19 Patients while Breathing, Talking, and Singing.
    Clin Infect Dis. 2021 Aug 6. pii: 6343417. doi: 10.1093.
    

    >> Share

    
    
29. BANNO M, Tsujimoto Y, Ishikane M
    Need for more randomized controlled trials with rigorous methodology to confirm that ivermectin is not a viable option for the treatment of coronavirus disease.
    Clin Infect Dis. 2021 Aug 6. pii: 6343415. doi: 10.1093.
    

    >> Share

    
    
30. TENFORDE MW, Patel MM, Ginde AA, Douin DJ, et al
    Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States.
    Clin Infect Dis. 2021 Aug 6. pii: 6343399. doi: 10.1093.
    

    >> Share

    
    

    
    Emerg Infect Dis

31. TRUFFOT A, Andreani J, Le Marechal M, Caporossi A, et al
    SARS-CoV-2 Variants in Immunocompromised Patient Given Antibody Monotherapy.
    Emerg Infect Dis. 2021;27.
    

    >> Share

    
    
32. BADR DA, Picone O, Bevilacqua E, Carlin A, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 and Pregnancy Outcomes According to Gestational Age at Time of Infection.
    Emerg Infect Dis. 2021;27.
    

    >> Share

    
    
33. SHUKLA BS, Warde PR, Knott E, Arenas S, et al
    Bloodstream Infection Risk, Incidence, and Deaths for Hospitalized Patients during Coronavirus Disease Pandemic.
    Emerg Infect Dis. 2021;27.
    

    >> Share

    
    

    
    Eur J Radiol

34. VAN HEUSDEN HC, Swartz JE, Chargi N, de Jong PA, et al
    Feasibility of assessment of skeletal muscle mass on a single cross-sectional image at the level of the fourth thoracic vertebra.
    Eur J Radiol. 2021;142:109879.
    

    >> Share

    
    

    
    Graefes Arch Clin Exp Ophthalmol

35. ERREN TC, Lewis P
    Secret hiding places in the eye and beyond: what about after SARS-CoV-2 infection?
    Graefes Arch Clin Exp Ophthalmol. 2021 Aug 3. pii: 10.1007/s00417-021-05323.
    

    >> Share

    
    

    
    Infect Control Hosp Epidemiol

36. SCHWARTZ KL, Muller MP, Williams V, Harry R, et al
    COVID-19 risk among healthcare workers performing nasopharyngeal testing.
    Infect Control Hosp Epidemiol. 2021 Aug 2:1-7. doi: 10.1017/ice.2021.
    

    >> Share

    
    
37. LEWIS SS, Kalu IC, Seidelman J, Anderson DJ, et al
    Challenges in Hospital-Acquired COVID-19 Surveillance and Attribution of Infection Source.
    Infect Control Hosp Epidemiol. 2021 Aug 2:1-11. doi: 10.1017/ice.2021.
    

    >> Share

    
    
38. MELETIS G, Gkeka I, Tychala A, Fyntanidou B, et al
    Laboratory evaluation of the Abbott ID NOW rapid SARS-CoV-2 amplification assay and its potential use in the emergency department.
    Infect Control Hosp Epidemiol. 2021 Aug 2:1-5. doi: 10.1017/ice.2021.
    

    >> Share

    
    
39. NOWROOZI A, Rezaei N
    SARS-CoV-2 delta variant of concern breakthrough infections: Are vaccines failing us?
    Infect Control Hosp Epidemiol. 2021 Aug 6:1-4. doi: 10.1017/ice.2021.
    

    >> Share

    
    
40. SCHULZ-STUBNER S, Elke P
    Transmission of SARS CoV2 among health careworkers (HCW) during three waves of the SARS-CoV 2 pandemic in Germany: Results of an anonymous survey.
    Infect Control Hosp Epidemiol. 2021 Aug 2:1-7. doi: 10.1017/ice.2021.
    

    >> Share

    
    
41. WEE LE, Conceicao EP, Aung MK, Oo AM, et al
    Rostered routine testing for healthcare workers and universal inpatient screening: the role of expanded hospital surveillance during an outbreak of COVID-19 in the surrounding community.
    Infect Control Hosp Epidemiol. 2021 Aug 6:1-9. doi: 10.1017/ice.2021.
    

    >> Share

    
    
42. JAMAL SA, Farooq MU, Bidari V
    Challenges associated with using Core Threshold (Ct) value of RT-PCR as a criteria for infectiousness of Covid-19 patients in India.
    Infect Control Hosp Epidemiol. 2021 Aug 2:1-6. doi: 10.1017/ice.2021.
    

    >> Share

    
    
43. LIANG Q, Sun C, Liu H, Zhang X, et al
    Vaccination Remains the First Choice to Control the Spread of Delta and Other Variants of SARS-CoV-2.
    Infect Control Hosp Epidemiol. 2021 Aug 6:1-4. doi: 10.1017/ice.2021.
    

    >> Share

    
    
44. MOORE SE, Wilde AM, Bohn BC, Song M, et al
    Antimicrobial Stewardship in Patients with Confirmed COVID-19.
    Infect Control Hosp Epidemiol. 2021 Aug 2:1-9. doi: 10.1017/ice.2021.
    

    >> Share

    
    
45. RIVERA F, Huerta S, Ahn KW, Munoz-Price LS, et al
    Incidence rate of SARS-CoV-2 among nurses in COVID-19 units vs. non-COVID-19-units at a large academic medical center.
    Infect Control Hosp Epidemiol. 2021 Aug 2:1-7. doi: 10.1017/ice.2021.
    

    >> Share

    
    
46. HARITA S, Hamaguchi J, Shimizu K, Honda H, et al
    Respiratory extracorporeal membrane oxygenation and central-line-associated bloodstream infection: Experience at a tertiary-care center during the coronavirus disease 2019 (COVID-19) pandemic.
    Infect Control Hosp Epidemiol. 2021 Aug 2:1-3. doi: 10.1017/ice.2021.
    

    >> Share

    
    
47. APISARNTHANARAK A, Nantapisal S, Pienthong T, Apisarnthanarak P, et al
    Healthcare-associated Transmission of COVID-19 Among Thai Healthcare Personnel Who Receive 2 Doses of a COVID-19 Vaccine: A Call for Considering a Booster Dose.
    Infect Control Hosp Epidemiol. 2021 Aug 6:1-9. doi: 10.1017/ice.2021.
    

    >> Share

    
    
48. HENDERSON DK, Haessler S, Weber DJ
    The coronavirus disease 2019 (COVID-19) pandemic-Looking back and looking forward.
    Infect Control Hosp Epidemiol. 2021 Aug 2:1-6. doi: 10.1017/ice.2021.
    

    >> Share

    
    

    
    Int J Infect Dis

49. YARANAGULA SD, Koduri VKC
    DimachkieSpectrum of Acute Neuropathy Associated with Covid-19: Clinical and electrophysiological study of 13 patients from a single center.
    Int J Infect Dis. 2021 Jul 29. pii: S1201-9712(21)00621.
    

    >> Share

    
    
50. QUACH HL, Nguyen KC, Hoang NA, Pham TQ, et al
    Association of public health interventions and COVID-19 incidence in Vietnam, January to December 2020.
    Int J Infect Dis. 2021 Jul 28. pii: S1201-9712(21)00600.
    

    >> Share

    
    
51. CLARO F, Silva D, Rodriguez M, Rangel R, et al
    IgG Antibody response to the Sputnik V vaccine: previous SARS-CoV-2 seropositive individuals might need just one vaccine dose.
    Int J Infect Dis. 2021 Jul 31. pii: S1201-9712(21)00626.
    

    >> Share

    
    
52. CHAU NVV, Nhan LNT, Nguyet LA, Tu NTK, et al
    Absence of SARS-CoV-2 antibodies in pre-pandemic plasma from children and adults in Vietnam.
    Int J Infect Dis. 2021 Jul 30. pii: S1201-9712(21)00629.
    

    >> Share

    
    
53. PATINO LH, Ballesteros N, Munoz M, Castaneda S, et al
    SARS-CoV-2 in transit: characterization of SARS-CoV-2 genomes from Venezuelan migrants in Colombia.
    Int J Infect Dis. 2021 Jul 29. pii: S1201-9712(21)00624.
    

    >> Share

    
    
54. AMIR M, Yoseph H, Farisi ATA, Phie JKP, et al
    Symptomatic Bradycardia in Covid-19 Hospitalized Patients: a Case Series.
    Int J Infect Dis. 2021 Jul 29. pii: S1201-9712(21)00625.
    

    >> Share

    
    
55. CHEN YH, Fang CT, Huang YL
    Effect of Non-lockdown Social Distancing and Testing-Contact Tracing During a COVID-19 Outbreak in Daegu, South Korea, February to April 2020: A Modeling Study.
    Int J Infect Dis. 2021 Jul 29. pii: S1201-9712(21)00614.
    

    >> Share

    
    
56. VELASQUEZ SR, Jacques L, Dalal J, Sestito P, et al
    The toll of COVID-19 on African children: A descriptive analysis on the COVID-19-related morbidity and mortality among the pediatric population in Sub-Saharan Africa.
    Int J Infect Dis. 2021 Jul 28. pii: S1201-9712(21)00616.
    

    >> Share

    
    
57. PERKMANN T, Perkmann-Nagele N, Mucher P, Radakovics A, et al
    Initial SARS-CoV-2 vaccination response can predict booster response for BNT162b2 but not for AZD1222.
    Int J Infect Dis. 2021 Jul 28. pii: S1201-9712(21)00620.
    

    >> Share

    
    
58. PALOMBA E, Carrabba M, Zuglian G, Alagna L, et al
    Treatment of SARS-CoV-2 Relapse with Remdesivir and Neutralizing Antibodies Cocktail in a Patient with X-Linked Agammaglobulinemia.
    Int J Infect Dis. 2021 Jul 28. pii: S1201-9712(21)00619.
    

    >> Share

    
    

    
    Intensive Care Med

59. ROUZE A, Lemaitre E, Nseir S
    COVID-19-associated invasive pulmonary aspergillosis: high incidence or difficult diagnosis?
    Intensive Care Med. 2021 Aug 3. pii: 10.1007/s00134-021-06499.
    

    >> Share

    
    

    
    J Infect

60. BARBOSA GR, Moreira LVL, Justo AFO, Perosa AH, et al
    Rapid spread and high impact of the variant of concern P.1 in the largest city of Brazil.
    J Infect. 2021;83:119-145.
    

    >> Share

    
    
61. FERNANDEZ-DE-LAS-PENAS C, Torres-Macho J, Velasco-Arribas M, Arias-Navalon JA, et al
    Similar prevalence of long-term post-COVID symptoms in patients with asthma: A case-control study.
    J Infect. 2021;83:237-279.
    

    >> Share

    
    
62. MILLER E, Waight PA, Andrews NJ, McOwat K, et al
    Transmission of SARS-CoV-2 in the household setting: a prospective cohort study in children and adults in England.
    J Infect. 2021 Aug 1. pii: S0163-4453(21)00380.
    

    >> Share

    
    
63. LUMLEY SF, Constantinides B, Sanderson N, Rodger G, et al
    Epidemiological data and genome sequencing reveals that nosocomial transmission of SARS-CoV-2 is underestimated and mostly mediated by a small number of highly infectious individuals.
    J Infect. 2021 Jul 28. pii: S0163-4453(21)00377.
    

    >> Share

    
    
64. BENE MC, Bittencourt MC, Chevallier P
    Post-SARS-CoV-2 vaccination specific antibody decrease : let's get the half-full glass perspective.
    J Infect. 2021 Jul 28. pii: S0163-4453(21)00370.
    

    >> Share

    
    
65. FERNANDEZ-DE-LAS-PENAS C, Palacios-Cena D, Gomez-Mayordomo V, Rodriuez-Jimenez J, et al
    Long-term post-COVID symptoms and associated risk factors in previously hospitalized patients: A multicenter study.
    J Infect. 2021;83:237-279.
    

    >> Share

    
    

    
    J Med Virol

66. CASSUTO NG, Gravier A, Colin M, Theillay A, et al
    Evaluation of a SARS-CoV-2 antigen-detecting rapid diagnostic test as a self-test: diagnostic performance and usability.
    J Med Virol. 2021 Jul 31. doi: 10.1002/jmv.27249.
    

    >> Share

    
    
67. DESHPANDE K, Pt U, Kaduskar O, Vijay N, et al
    Performance assessment of seven SARS-CoV-2 IgG enzyme linked immunosorbent assays.
    J Med Virol. 2021 Jul 31. doi: 10.1002/jmv.27251.
    

    >> Share

    
    
68. UNSALER S, Okan A, Tekin S, Hafiz AM, et al
    Comparison of nasopharyngeal swab and nasopharyngeal aspiration in adults for SARS-CoV-2 identification using reverse transcription-polymerase chain reaction.
    J Med Virol. 2021 Jul 31. doi: 10.1002/jmv.27250.
    

    >> Share

    
    
69. WERFEL S, Jakob CEM, Borgmann S, Schneider J, et al
    Development and Validation of a Simplified Risk Score for the Prediction of Critical COVID-19 Illness in Newly Diagnosed Patients.
    J Med Virol. 2021 Jul 31. doi: 10.1002/jmv.27252.
    

    >> Share

    
    
70. ABDULAH DM
    ABDULAHPrevalence and correlates of COVID-19 vaccine hesitancy in general public in Iraqi Kurdistan: A cross-sectional study.
    J Med Virol. 2021 Aug 4. doi: 10.1002/jmv.27255.
    

    >> Share

    
    
71. GUAN Y, Chen C, Guo A, Wei J, et al
    Prolonged Symptom Onset to Admission Time is Associated with Severe Coronavirus Disease: A Meta combined Propensity-adjusted Analysis.
    J Med Virol. 2021 Aug 4. doi: 10.1002/jmv.27253.
    

    >> Share

    
    
72. ESSAR MY, Kazmi SK, Hasan MM, Santos Costa ACD, et al
    The rampant use of cow-dung to treat COVID-19: Is India at the brink of a zoonotic disease outbreak?
    J Med Virol. 2021 Aug 5. doi: 10.1002/jmv.27258.
    

    >> Share

    
    
73. QURESHI QH, Ashraf T, Rehman K, Khosa MK, et al
    Therapeutic interventions of remdesivir in diabetic and non-diabetic COVID-19 patients: A prospective observational study conducted on Pakistani population.
    J Med Virol. 2021 Aug 5. doi: 10.1002/jmv.27256.
    

    >> Share

    
    

    
    J Travel Med

74. CHEN LH, Petersen E, Blumberg L, Piyaphanee W, et al
    COVID-19 health passes: Current status and prospects for a global approach.
    J Travel Med. 2021 Aug 3. pii: 6338088. doi: 10.1093.
    

    >> Share

    
    
75. SAPKAL GN, Yadav PD, Sahay RR, Deshpande G, et al
    Neutralization of Delta variant with sera of Covishield vaccinees and COVID-19 recovered vaccinated individuals.
    J Travel Med. 2021 Aug 3. pii: 6338089. doi: 10.1093.
    

    >> Share

    
    
76. TSUCHIHASHI Y, Yamagishi T, Suzuki M, Sekizuka T, et al
    High attack rate of SARS-CoV-2 infections during a bus tour in Japan.
    J Travel Med. 2021 Jul 23. pii: 6326851. doi: 10.1093.
    

    >> Share

    
    

    
    JAMA

77. DIAZ GA, Parsons GT, Gering SK, Meier AR, et al
    Myocarditis and Pericarditis After Vaccination for COVID-19.
    JAMA. 2021 Aug 4. pii: 2782900. doi: 10.1001/jama.2021.13443.
    

    >> Share

    
    

    
    Lancet

78. THE LANCET
    Health in the USA: under examination and under repair.
    Lancet. 2021;397:641.
    

    >> Share

    
    
79. DAS P
    Sharrelle Barber: at the intersection of place, race, and health.
    Lancet. 2021;397:659.
    

    >> Share

    
    
80. MMONU NA, Aifah A, Onakomaiya D, Ogedegbe G, et al
    Why the global health community should support the EndSARS movement in Nigeria.
    Lancet. 2021;397:666-667.
    

    >> Share

    
    
81. MAFHAM M, Baigent C
    What is the association of COVID-19 with heart attacks and strokes?
    Lancet. 2021 Jul 29. pii: S0140-6736(21)01071.
    

    >> Share

    
    
82. LURIE N, Keusch GT, Dzau VJ
    Should global financing be the main priority for pandemic preparedness? - Authors' reply.
    Lancet. 2021;398:388-389.
    

    >> Share

    
    
83. KATSOULARIS I, Fonseca-Rodriguez O, Farrington P, Lindmark K, et al
    Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study.
    Lancet. 2021 Jul 29. pii: S0140-6736(21)00896.
    

    >> Share

    
    
84. PAN D, Martin CA, Nazareth J, Nevill CR, et al
    Ethnic disparities in COVID-19: increased risk of infection or severe disease?
    Lancet. 2021;398:389-390.
    

    >> Share

    
    
85. MATHUR R, Rentsch CT, Morton CE, Eggo RM, et al
    Ethnic disparities in COVID-19: increased risk of infection or severe disease? - Authors' reply.
    Lancet. 2021;398:390.
    

    >> Share

    
    
86. KAMPMANN B, Okomo U
    COVID-19 vaccines for children in LMICs: another equity issue.
    Lancet. 2021 Jul 30. pii: S0140-6736(21)01748.
    

    >> Share

    
    

    
    Lancet Infect Dis

87. BALAKRISHNAN VS
    Impact of COVID-19 on migrants and refugees.
    Lancet Infect Dis. 2021;21:1076-1077.
    

    >> Share

    
    
88. CHEN PZ, Koopmans M, Fisman DN, Gu FX, et al
    Understanding why superspreading drives the COVID-19 pandemic but not the H1N1 pandemic.
    Lancet Infect Dis. 2021 Aug 2. pii: S1473-3099(21)00406.
    

    >> Share

    
    
89. TENBUSCH M, Schumacher S, Vogel E, Priller A, et al
    Heterologous prime-boost vaccination with ChAdOx1 nCoV-19 and BNT162b2.
    Lancet Infect Dis. 2021 Jul 29. pii: S1473-3099(21)00420.
    

    >> Share

    
    
90. ESSO L, Epee E, Bilounga C, Abah A, et al
    Cameroon's bold response to the COVID-19 pandemic during the first and second waves.
    Lancet Infect Dis. 2021;21:1064-1065.
    

    >> Share

    
    
91. LONG CM, Marzi A
    Biodefence research two decades on: worth the investment?
    Lancet Infect Dis. 2021;21:e222-e233.
    

    >> Share

    
    

    
    MMWR Morb Mortal Wkly Rep

92. BROWN CM, Vostok J, Johnson H, Burns M, et al
    Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings - Barnstable County, Massachusetts, July 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1059-1062.
    

    >> Share

    
    
93. HAUSE AM, Gee J, Baggs J, Abara WE, et al
    COVID-19 Vaccine Safety in Adolescents Aged 12-17 Years - United States, December 14, 2020-July 16, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1053-1058.
    

    >> Share

    
    

    
    N Engl J Med

94. GOLIGHER EC, Bradbury CA, McVerry BJ, Lawler PR, et al
    Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.
    N Engl J Med. 2021 Aug 4. doi: 10.1056/NEJMoa2103417.
    

    >> Share

    
    
95. O'BRIEN MP, Forleo-Neto E, Musser BJ, Isa F, et al
    Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19.
    N Engl J Med. 2021 Aug 4. doi: 10.1056/NEJMoa2109682.
    

    >> Share

    
    
96. MOON S, Alonso Ruiz A, Vieira M
    Averting Future Vaccine Injustice.
    N Engl J Med. 2021;385:193-196.
    

    >> Share

    
    
97. TEN CATE H
    Surviving Covid-19 with Heparin?
    N Engl J Med. 2021 Aug 4. doi: 10.1056/NEJMe2111151.
    

    >> Share

    
    
98. COREY L, Beyrer C, Cohen MS, Michael NL, et al
    SARS-CoV-2 Variants in Patients with Immunosuppression.
    N Engl J Med. 2021;385:562-566.
    

    >> Share

    
    
99. LAWLER PR, Goligher EC, Berger JS, Neal MD, et al
    Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
    N Engl J Med. 2021 Aug 4. doi: 10.1056/NEJMoa2105911.
    

    >> Share

    
    

    
    Nature

100. ELSE H
     COVID 'Fast Grants' sped up pandemic science.
     Nature. 2021 Aug 3. pii: 10.1038/d41586-021-02111.
     

     >> Share

     
     
101. MALLAPATY S
     The COVID vaccine pioneer behind southeast Asia's first mRNA shot.
     Nature. 2021;594:163.
     

     >> Share

     
     
102. DORAN M
     We need to talk about post-pandemic lectures.
     Nature. 2021 Jul 30. pii: 10.1038/d41586-021-02112.
     

     >> Share

     
     
103. MAXMEN A
     COVID boosters for wealthy nations spark outrage.
     Nature. 2021 Jul 30. pii: 10.1038/d41586-021-02109.
     

     >> Share

     
     
104. DAI H, Saccardo S, Han MA, Roh L, et al
     Behavioral Nudges Increase COVID-19 Vaccinations.
     Nature. 2021 Aug 2. pii: 10.1038/s41586-021-03843.
     

     >> Share

     
     
105. MALLAPATY S
     The coronavirus is rife in common US deer.
     Nature. 2021 Aug 2. pii: 10.1038/d41586-021-02110.
     

     >> Share

     
     
106. ROSEN J
     Pandemic upheaval offers a huge natural experiment.
     Nature. 2021;596:149-151.
     

     >> Share

     
     
107. PATEL MS
     Text-message nudges encourage COVID vaccination.
     Nature. 2021 Aug 2. pii: 10.1038/d41586-021-02043.
     

     >> Share

     
     
108. REARDON S
     Flawed ivermectin preprint highlights challenges of COVID drug studies.
     Nature. 2021 Aug 2. pii: 10.1038/d41586-021-02081.
     

     >> Share

     
     
109. MALLAPATY S
     Delta threatens rural regions that dodged earlier COVID waves.
     Nature. 2021 Aug 6. pii: 10.1038/d41586-021-02146.
     

     >> Share

     
     
110. CALLAWAY E
     COVID vaccine boosters: the most important questions.
     Nature. 2021 Aug 5. pii: 10.1038/d41586-021-02158.
     

     >> Share

     
     
111. AREZKI R
     Cash payments in Africa could boost vaccine uptake.
     Nature. 2021;596:9.
     

     >> Share

     
     
112. BALL P
     Surprise dip in UK COVID cases baffles researchers.
     Nature. 2021 Aug 3. pii: 10.1038/d41586-021-02125.
     

     >> Share

     
     
113. COMBES AJ, Courau T, Kuhn NF, Hu KH, et al
     Publisher Correction: Global absence and targeting of protective immune states in severe COVID-19.
     Nature. 2021 Aug 2. pii: 10.1038/s41586-021-03718.
     

     >> Share

     
     
114. DE GASPARO R, Pedotti M, Simonelli L, Nickl P, et al
     Publisher Correction: Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice.
     Nature. 2021 Aug 3. pii: 10.1038/s41586-021-03719.
     

     >> Share

     
     
115. KOZLOV M
     A simple text has the power to increase COVID vaccinations.
     Nature. 2021 Aug 2. pii: 10.1038/d41586-021-02108.
     

     >> Share

     
     

     
     Radiology

116. ISAAK A, Feisst A, Luetkens JA
     Myocarditis Following COVID-19 Vaccination.
     Radiology. 2021 Aug 3:211766. doi: 10.1148/radiol.2021211766.
     

     >> Share

     
     

     
     Science

117. ALWAN NA
     The road to addressing Long Covid.
     Science. 2021;373:491-493.
     

     >> Share

     
     
118. WADMAN M
     The overlooked superpower of mRNA vaccines.
     Science. 2021;373:479.
     

     >> Share

     
     
119. PINTO D, Sauer MM, Czudnochowski N, Low JS, et al
     Broad betacoronavirus neutralization by a stem helix-specific human antibody.
     Science. 2021 Aug 3. pii: science.abj3321. doi: 10.1126/science.abj3321.
     

     >> Share

     
     

Free Medical Abstracts
Privacy Policy
Sponsors
Share